Literature DB >> 6297771

Disproportionate expression of the two nonallelic rat insulin genes in a pancreatic tumor is due to translational control.

B Cordell, D Diamond, S Smith, J Pünter, H H Schöne, H M Goodman.   

Abstract

The expression of the two nonallelic but highly homologous rat insulin genes (1 and 2) in a transplantable beta-cell tumor is found to be 10-fold higher for rat1 insulin than rat2 insulin, while in normal pancreatic tissue there are approximately equal amounts of each protein. No large sequence rearrangements of the genes were apparent by restriction analysis of the tumor DNA, and both genes were found to be specifically hypomethylated in the tumor as compared with other nonpancreatic tissue. Equivalent amounts of both insulin 1 and 2 precursor transcripts, as well as stable, mature mRNAs were detected in the tumor. However, two-dimensional gel analysis of immunoprecipitated rat1 and rat2 preproinsulins synthesized in vitro revealed a 10:1 ratio of rat1 to rat2 proteins. A 1:1 ratio was obtained when the tumor mRNA was treated in vitro with vaccinia virus capping extract, suggesting a structural modification at the 5' terminus of the rat2 mRNA. These results are discussed in the context of insulin regulation by glucose, shown to be due to translational control.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6297771     DOI: 10.1016/0092-8674(82)90309-9

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  17 in total

1.  Extinction of insulin gene expression in hybrids between beta cells and fibroblasts is accompanied by loss of the putative beta-cell-specific transcription factor IEF1.

Authors:  D Leshkowitz; M D Walker
Journal:  Mol Cell Biol       Date:  1991-03       Impact factor: 4.272

2.  Modifications of the 5' cap of mRNAs during Xenopus oocyte maturation: independence from changes in poly(A) length and impact on translation.

Authors:  D L Gillian-Daniel; N K Gray; J Aström; A Barkoff; M Wickens
Journal:  Mol Cell Biol       Date:  1998-10       Impact factor: 4.272

3.  Identification of a pancreatic beta-cell insulin gene transcription factor that binds to and appears to activate cell-type-specific expression: its possible relationship to other cellular factors that bind to a common insulin gene sequence.

Authors:  J Whelan; S R Cordle; E Henderson; P A Weil; R Stein
Journal:  Mol Cell Biol       Date:  1990-04       Impact factor: 4.272

4.  The COUP transcription factor binds to an upstream promoter element of the rat insulin II gene.

Authors:  Y P Hwung; D T Crowe; L H Wang; S Y Tsai; M J Tsai
Journal:  Mol Cell Biol       Date:  1988-05       Impact factor: 4.272

5.  Monoamine oxidases A and B are differentially regulated by glucocorticoids and "aging" in human skin fibroblasts.

Authors:  S B Edelstein; X O Breakefield
Journal:  Cell Mol Neurobiol       Date:  1986-06       Impact factor: 5.046

6.  Characterization of the size and 5' cap of messenger RNA encoding neurophysin precursors.

Authors:  C J Hough; I M Chaiken
Journal:  Nucleic Acids Res       Date:  1984-05-25       Impact factor: 16.971

7.  Translational regulation of influenza virus mRNAs.

Authors:  K Yamanaka; A Ishihama; K Nagata
Journal:  Virus Genes       Date:  1988-10       Impact factor: 2.332

8.  Ren-1 and Ren-2 loci are expressed in mouse kidney.

Authors:  L J Field; K W Gross
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

9.  Adaptation to supraphysiologic levels of insulin gene expression in transgenic mice: evidence for the importance of posttranscriptional regulation.

Authors:  B Schnetzler; G Murakawa; D Abalos; P Halban; R Selden
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

10.  An in vivo analysis of pancreatic protein and insulin biosynthesis in a rat model for non-insulin-dependent diabetes.

Authors:  M A Permutt; K Kakita; P Malinas; I Karl; S Bonner-Weir; G Weir; S J Giddings
Journal:  J Clin Invest       Date:  1984-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.